Biorasi
@biorasi.bsky.social
Biorasi is a global clinical research organization (CRO) that delivers speed-to-market strategies for small to midsized biotech and biopharma sponsors. Find our podcast at >> https://biorasi.com/few-far-between-podcast/
Pinned
Episode 66: Mark Abelson, Founder of Ora Clinical
YouTube video by Biorasi
youtu.be
Are #clinicaltrial protocols a true art form?
Find out in a new episode of the @biorasi.bsky.social Few & Far Between podcast, with guest Mark Ableson, founder of #OraClinical.
Listen to this audio episode on our YouTube channel >> youtu.be/CHL1F76TZCo
Find out in a new episode of the @biorasi.bsky.social Few & Far Between podcast, with guest Mark Ableson, founder of #OraClinical.
Listen to this audio episode on our YouTube channel >> youtu.be/CHL1F76TZCo
Is the mast cell the most fascinating cell in the human body?
Find out in the latest episode of the @biorasi.bsky.social Few and Far Between podcast with guest Mark Abelson, founder of #oraclinical.
Listen to this audio episode on our YouTube channel >> youtu.be/CHL1F76TZCo #mastcell
Find out in the latest episode of the @biorasi.bsky.social Few and Far Between podcast with guest Mark Abelson, founder of #oraclinical.
Listen to this audio episode on our YouTube channel >> youtu.be/CHL1F76TZCo #mastcell
December 23, 2025 at 2:18 PM
Is the mast cell the most fascinating cell in the human body?
Find out in the latest episode of the @biorasi.bsky.social Few and Far Between podcast with guest Mark Abelson, founder of #oraclinical.
Listen to this audio episode on our YouTube channel >> youtu.be/CHL1F76TZCo #mastcell
Find out in the latest episode of the @biorasi.bsky.social Few and Far Between podcast with guest Mark Abelson, founder of #oraclinical.
Listen to this audio episode on our YouTube channel >> youtu.be/CHL1F76TZCo #mastcell
Are #clinicaltrial protocols a true art form?
Find out in a new episode of the @biorasi.bsky.social Few & Far Between podcast, with guest Mark Ableson, founder of #OraClinical.
Listen to this audio episode on our YouTube channel >> youtu.be/CHL1F76TZCo
Find out in a new episode of the @biorasi.bsky.social Few & Far Between podcast, with guest Mark Ableson, founder of #OraClinical.
Listen to this audio episode on our YouTube channel >> youtu.be/CHL1F76TZCo
Episode 66: Mark Abelson, Founder of Ora Clinical
YouTube video by Biorasi
youtu.be
December 16, 2025 at 2:16 PM
Are #clinicaltrial protocols a true art form?
Find out in a new episode of the @biorasi.bsky.social Few & Far Between podcast, with guest Mark Ableson, founder of #OraClinical.
Listen to this audio episode on our YouTube channel >> youtu.be/CHL1F76TZCo
Find out in a new episode of the @biorasi.bsky.social Few & Far Between podcast, with guest Mark Ableson, founder of #OraClinical.
Listen to this audio episode on our YouTube channel >> youtu.be/CHL1F76TZCo
Tomorrow on the @biorasi.bsky.social Few & Far Between podcast, host Chris O'Brien welcomes Dr. Mark Abelson, founder of #Ora and a pioneer in the #clinicaltrial industry.
We'll zoom in on inflammatory triggers, the importance of learning, and building #CROs from scratch.
See you then!
We'll zoom in on inflammatory triggers, the importance of learning, and building #CROs from scratch.
See you then!
December 15, 2025 at 3:46 PM
Tomorrow on the @biorasi.bsky.social Few & Far Between podcast, host Chris O'Brien welcomes Dr. Mark Abelson, founder of #Ora and a pioneer in the #clinicaltrial industry.
We'll zoom in on inflammatory triggers, the importance of learning, and building #CROs from scratch.
See you then!
We'll zoom in on inflammatory triggers, the importance of learning, and building #CROs from scratch.
See you then!
How much do you need to risk for a big scientific breakthrough?
Check out the latest episode of the @biorasi.bsky.social Few and Far Between podcast, with guest Amit Etkin, CEO of #AltoNeuro. youtu.be/Q4PmPumy0rs
Check out the latest episode of the @biorasi.bsky.social Few and Far Between podcast, with guest Amit Etkin, CEO of #AltoNeuro. youtu.be/Q4PmPumy0rs
How much do you need to risk for a big scientific breakthrough?
YouTube video by Biorasi
youtu.be
December 5, 2025 at 6:46 PM
How much do you need to risk for a big scientific breakthrough?
Check out the latest episode of the @biorasi.bsky.social Few and Far Between podcast, with guest Amit Etkin, CEO of #AltoNeuro. youtu.be/Q4PmPumy0rs
Check out the latest episode of the @biorasi.bsky.social Few and Far Between podcast, with guest Amit Etkin, CEO of #AltoNeuro. youtu.be/Q4PmPumy0rs
Building your first #biotech?
Learn more about what to take on your journey in the latest episode of the @biorasi.bsky.social Few and Far Between podcast, with guest Amit Etkin, Founder and CEO of #AltoNeuro. youtu.be/r5Hl7dhXDZU
Learn more about what to take on your journey in the latest episode of the @biorasi.bsky.social Few and Far Between podcast, with guest Amit Etkin, Founder and CEO of #AltoNeuro. youtu.be/r5Hl7dhXDZU
youtu.be
December 2, 2025 at 1:32 PM
Building your first #biotech?
Learn more about what to take on your journey in the latest episode of the @biorasi.bsky.social Few and Far Between podcast, with guest Amit Etkin, Founder and CEO of #AltoNeuro. youtu.be/r5Hl7dhXDZU
Learn more about what to take on your journey in the latest episode of the @biorasi.bsky.social Few and Far Between podcast, with guest Amit Etkin, Founder and CEO of #AltoNeuro. youtu.be/r5Hl7dhXDZU
With biotech, is it the destination, the journey, or both?
Find out on the @biorasi.bsky.social Few & Far Between podcast, with guest Amit Etkin, Founder and CEO #altoneuro.
Watch it today on our YouTube channel >> youtu.be/Dl3QJUCGstA
#schizophrenia #biotech #placebos #biomarkers #psychiatry
Find out on the @biorasi.bsky.social Few & Far Between podcast, with guest Amit Etkin, Founder and CEO #altoneuro.
Watch it today on our YouTube channel >> youtu.be/Dl3QJUCGstA
#schizophrenia #biotech #placebos #biomarkers #psychiatry
November 24, 2025 at 7:54 PM
With biotech, is it the destination, the journey, or both?
Find out on the @biorasi.bsky.social Few & Far Between podcast, with guest Amit Etkin, Founder and CEO #altoneuro.
Watch it today on our YouTube channel >> youtu.be/Dl3QJUCGstA
#schizophrenia #biotech #placebos #biomarkers #psychiatry
Find out on the @biorasi.bsky.social Few & Far Between podcast, with guest Amit Etkin, Founder and CEO #altoneuro.
Watch it today on our YouTube channel >> youtu.be/Dl3QJUCGstA
#schizophrenia #biotech #placebos #biomarkers #psychiatry
NEXT WEEK: Host Chris O'Brien welcomes Amit Etkin, Founder and CEO at #altoneuro and Professor of Psychiatry at @stanfordmedicine.bsky.social, to the @biorasi.bsky.social Few & Far Between podcast.
Don't head into Thanksgiving before you watch this episode next week. youtu.be/YZwy-Tulagg
Don't head into Thanksgiving before you watch this episode next week. youtu.be/YZwy-Tulagg
NEXT WEEK's EPISODE: Amit Etkin, Founder and Professor of Psychiatry at Stanford
YouTube video by Biorasi
youtu.be
November 19, 2025 at 1:43 PM
NEXT WEEK: Host Chris O'Brien welcomes Amit Etkin, Founder and CEO at #altoneuro and Professor of Psychiatry at @stanfordmedicine.bsky.social, to the @biorasi.bsky.social Few & Far Between podcast.
Don't head into Thanksgiving before you watch this episode next week. youtu.be/YZwy-Tulagg
Don't head into Thanksgiving before you watch this episode next week. youtu.be/YZwy-Tulagg
If #AI is superior to human involvement in #drugdevelopment, why aren't more #biotechs using it?
Find out on the latest episode of the @biorasi.bsky.social Few and Far Between podcast, as host Chris O'Brien welcomes Justin Stebbing to the show >> youtu.be/-Yl0SG0cQJM
Find out on the latest episode of the @biorasi.bsky.social Few and Far Between podcast, as host Chris O'Brien welcomes Justin Stebbing to the show >> youtu.be/-Yl0SG0cQJM
If #AI is superior to human involvement in #drugdevelopment, why aren't more #biotechs using it?
YouTube video by Biorasi
youtu.be
November 17, 2025 at 2:18 PM
If #AI is superior to human involvement in #drugdevelopment, why aren't more #biotechs using it?
Find out on the latest episode of the @biorasi.bsky.social Few and Far Between podcast, as host Chris O'Brien welcomes Justin Stebbing to the show >> youtu.be/-Yl0SG0cQJM
Find out on the latest episode of the @biorasi.bsky.social Few and Far Between podcast, as host Chris O'Brien welcomes Justin Stebbing to the show >> youtu.be/-Yl0SG0cQJM
What's the most underrated skill for a #biotech CEO?
Join host Chris O'Brien and guest Bruce Leuchter, M.D. in the⚡lightning round⚡on the Biorasi Few & Far Between podcast >> youtu.be/Iy2bk7fEfl4
Join host Chris O'Brien and guest Bruce Leuchter, M.D. in the⚡lightning round⚡on the Biorasi Few & Far Between podcast >> youtu.be/Iy2bk7fEfl4
What's the most underrated skill for a #biotech CEO?
YouTube video by Biorasi
youtu.be
November 12, 2025 at 1:25 PM
What's the most underrated skill for a #biotech CEO?
Join host Chris O'Brien and guest Bruce Leuchter, M.D. in the⚡lightning round⚡on the Biorasi Few & Far Between podcast >> youtu.be/Iy2bk7fEfl4
Join host Chris O'Brien and guest Bruce Leuchter, M.D. in the⚡lightning round⚡on the Biorasi Few & Far Between podcast >> youtu.be/Iy2bk7fEfl4
Will #GLP1's one day replace our morning coffee?
Find out in a special video episode of the @biorasi.bsky.social Few & Far Between podcast, with friend of the show, Professor Justin Stebbing.
Watch it today on our YouTube channel >> youtu.be/76tWn-OvCx8
Find out in a special video episode of the @biorasi.bsky.social Few & Far Between podcast, with friend of the show, Professor Justin Stebbing.
Watch it today on our YouTube channel >> youtu.be/76tWn-OvCx8
November 11, 2025 at 2:59 PM
Will #GLP1's one day replace our morning coffee?
Find out in a special video episode of the @biorasi.bsky.social Few & Far Between podcast, with friend of the show, Professor Justin Stebbing.
Watch it today on our YouTube channel >> youtu.be/76tWn-OvCx8
Find out in a special video episode of the @biorasi.bsky.social Few & Far Between podcast, with friend of the show, Professor Justin Stebbing.
Watch it today on our YouTube channel >> youtu.be/76tWn-OvCx8
NEXT WEEK: @biorasi.bsky.social debuts a new podcast segment on Tuesday, 11/11.
Host Chris O'Brien will be joined by guest, Professor Justin Stebbing, to explore the latest #biotech trends - from #precisionmedicine and #AI to #GLP1 and #chronicpain.
See you then!
youtu.be/iwuhAIe7ZvE
Host Chris O'Brien will be joined by guest, Professor Justin Stebbing, to explore the latest #biotech trends - from #precisionmedicine and #AI to #GLP1 and #chronicpain.
See you then!
youtu.be/iwuhAIe7ZvE
NEXT WEEK: @BiorasiCRO debuts a new podcast segment on Tuesday, 11/11.
YouTube video by Biorasi
youtu.be
November 7, 2025 at 1:30 PM
NEXT WEEK: @biorasi.bsky.social debuts a new podcast segment on Tuesday, 11/11.
Host Chris O'Brien will be joined by guest, Professor Justin Stebbing, to explore the latest #biotech trends - from #precisionmedicine and #AI to #GLP1 and #chronicpain.
See you then!
youtu.be/iwuhAIe7ZvE
Host Chris O'Brien will be joined by guest, Professor Justin Stebbing, to explore the latest #biotech trends - from #precisionmedicine and #AI to #GLP1 and #chronicpain.
See you then!
youtu.be/iwuhAIe7ZvE
ALERT: Biorasi's new video episode of the Few & Far Between podcast drops next week.
Host Chris O'Brien welcomes friend of the show, Justin Stebbing, for a new segment focusing on the latest #biotech trends of 2025.
See you next week! >> youtu.be/mSoxuAqiUnE
Host Chris O'Brien welcomes friend of the show, Justin Stebbing, for a new segment focusing on the latest #biotech trends of 2025.
See you next week! >> youtu.be/mSoxuAqiUnE
Welcoming Justin Stebbing back to the Few & Far Between podcast
YouTube video by Biorasi
youtu.be
November 4, 2025 at 7:32 PM
ALERT: Biorasi's new video episode of the Few & Far Between podcast drops next week.
Host Chris O'Brien welcomes friend of the show, Justin Stebbing, for a new segment focusing on the latest #biotech trends of 2025.
See you next week! >> youtu.be/mSoxuAqiUnE
Host Chris O'Brien welcomes friend of the show, Justin Stebbing, for a new segment focusing on the latest #biotech trends of 2025.
See you next week! >> youtu.be/mSoxuAqiUnE
"The importance of doing the right thing at the right time with the right asset." - Bruce Leuchter, M.D., CEO and President of #NeurvatiNeurosciences.
youtu.be/_IucWPZqbAM
youtu.be/_IucWPZqbAM
Highlights from Episode 63 with guest Bruce Leuchter, M.D. Neurvati Neurosciences
YouTube video by Biorasi
youtu.be
November 4, 2025 at 1:41 PM
"The importance of doing the right thing at the right time with the right asset." - Bruce Leuchter, M.D., CEO and President of #NeurvatiNeurosciences.
youtu.be/_IucWPZqbAM
youtu.be/_IucWPZqbAM
This Halloween, let’s put monsters back where they belong — in scary movies, not #clinicaltrials.
@biorasi.bsky.social: The CRO that doesn’t ghost you. 👻 Learn more about our core capabilities today >> biorasi.com/about-biorasi/
#Biorasi2025 #CROs #biotech #biopharma
@biorasi.bsky.social: The CRO that doesn’t ghost you. 👻 Learn more about our core capabilities today >> biorasi.com/about-biorasi/
#Biorasi2025 #CROs #biotech #biopharma
October 31, 2025 at 12:51 PM
This Halloween, let’s put monsters back where they belong — in scary movies, not #clinicaltrials.
@biorasi.bsky.social: The CRO that doesn’t ghost you. 👻 Learn more about our core capabilities today >> biorasi.com/about-biorasi/
#Biorasi2025 #CROs #biotech #biopharma
@biorasi.bsky.social: The CRO that doesn’t ghost you. 👻 Learn more about our core capabilities today >> biorasi.com/about-biorasi/
#Biorasi2025 #CROs #biotech #biopharma
What?! Even More Scary Stories from the Clinical Trial Crypt! Part 4: The Invisible Study
Prevent your #clinicaltrial updates from turning into a disappearing act.
It’s not magic. It’s @biorasi.bsky.social! Connect at >> biorasi.com/contact-us/ #Biorasi2025 #biotech #biopharma #CROs
Prevent your #clinicaltrial updates from turning into a disappearing act.
It’s not magic. It’s @biorasi.bsky.social! Connect at >> biorasi.com/contact-us/ #Biorasi2025 #biotech #biopharma #CROs
October 30, 2025 at 5:16 PM
What?! Even More Scary Stories from the Clinical Trial Crypt! Part 4: The Invisible Study
Prevent your #clinicaltrial updates from turning into a disappearing act.
It’s not magic. It’s @biorasi.bsky.social! Connect at >> biorasi.com/contact-us/ #Biorasi2025 #biotech #biopharma #CROs
Prevent your #clinicaltrial updates from turning into a disappearing act.
It’s not magic. It’s @biorasi.bsky.social! Connect at >> biorasi.com/contact-us/ #Biorasi2025 #biotech #biopharma #CROs
Even More Scary Stories from the Clinical Trial Crypt! 👻
It's spinning out of control - it's the Trial Spiral.
Don’t get the dizzies. Learn more about @biorasi.bsky.social rescue and recovery successes at >> biorasi.com/rescue-and-r... #Biorasi2025 #clinicaltrials #biotech #biopharma #CROs
It's spinning out of control - it's the Trial Spiral.
Don’t get the dizzies. Learn more about @biorasi.bsky.social rescue and recovery successes at >> biorasi.com/rescue-and-r... #Biorasi2025 #clinicaltrials #biotech #biopharma #CROs
October 30, 2025 at 12:14 PM
Even More Scary Stories from the Clinical Trial Crypt! 👻
It's spinning out of control - it's the Trial Spiral.
Don’t get the dizzies. Learn more about @biorasi.bsky.social rescue and recovery successes at >> biorasi.com/rescue-and-r... #Biorasi2025 #clinicaltrials #biotech #biopharma #CROs
It's spinning out of control - it's the Trial Spiral.
Don’t get the dizzies. Learn more about @biorasi.bsky.social rescue and recovery successes at >> biorasi.com/rescue-and-r... #Biorasi2025 #clinicaltrials #biotech #biopharma #CROs
How do you make #biotech marketing more impactful?
Find out in our latest episode of the @biorasi.bsky.social Few & Far Between podcast, with guest Kentaro Suzuki, CMO at @nautilus.bio.
Find this episode on your favorite streaming platform or visit >> bit.ly/FewandFarBet...
Find out in our latest episode of the @biorasi.bsky.social Few & Far Between podcast, with guest Kentaro Suzuki, CMO at @nautilus.bio.
Find this episode on your favorite streaming platform or visit >> bit.ly/FewandFarBet...
October 29, 2025 at 6:30 PM
How do you make #biotech marketing more impactful?
Find out in our latest episode of the @biorasi.bsky.social Few & Far Between podcast, with guest Kentaro Suzuki, CMO at @nautilus.bio.
Find this episode on your favorite streaming platform or visit >> bit.ly/FewandFarBet...
Find out in our latest episode of the @biorasi.bsky.social Few & Far Between podcast, with guest Kentaro Suzuki, CMO at @nautilus.bio.
Find this episode on your favorite streaming platform or visit >> bit.ly/FewandFarBet...
More Scary Stories from the Clinical Trial Crypt! 👻
Poor communication? It must be the Unresponsive Team.
This Halloween👻, choose @biorasi.bsky.social - a partner that’s alive and responsive. Find out more about our core capabilities today >> bit.ly/PartnerwithB... #Biorasi2025 #CROs
Poor communication? It must be the Unresponsive Team.
This Halloween👻, choose @biorasi.bsky.social - a partner that’s alive and responsive. Find out more about our core capabilities today >> bit.ly/PartnerwithB... #Biorasi2025 #CROs
October 29, 2025 at 4:49 PM
More Scary Stories from the Clinical Trial Crypt! 👻
Poor communication? It must be the Unresponsive Team.
This Halloween👻, choose @biorasi.bsky.social - a partner that’s alive and responsive. Find out more about our core capabilities today >> bit.ly/PartnerwithB... #Biorasi2025 #CROs
Poor communication? It must be the Unresponsive Team.
This Halloween👻, choose @biorasi.bsky.social - a partner that’s alive and responsive. Find out more about our core capabilities today >> bit.ly/PartnerwithB... #Biorasi2025 #CROs
Welcome to our first video episode of the @biorasi.bsky.social Few & Far Between podcast. Today, we welcome guest Bruce Leuchter, M.D., President and CEO of #Neurvati.
Watch it today! Find this episode on your favorite streaming platform or visit >> bit.ly/FewandFarBet... #Biorasi2025
Watch it today! Find this episode on your favorite streaming platform or visit >> bit.ly/FewandFarBet... #Biorasi2025
October 28, 2025 at 1:54 PM
Welcome to our first video episode of the @biorasi.bsky.social Few & Far Between podcast. Today, we welcome guest Bruce Leuchter, M.D., President and CEO of #Neurvati.
Watch it today! Find this episode on your favorite streaming platform or visit >> bit.ly/FewandFarBet... #Biorasi2025
Watch it today! Find this episode on your favorite streaming platform or visit >> bit.ly/FewandFarBet... #Biorasi2025
The new @biorasi.bsky.social video podcast debuts next week!
Host Chris O'Brien welcomes guest Bruce Leuchter, M.D., President and CEO of #neurvati. We'll also premiere our new Lightning Round - quick questions and inspired answers.
See you next week. #Biorasi2025 #neuroscience #CROs
Host Chris O'Brien welcomes guest Bruce Leuchter, M.D., President and CEO of #neurvati. We'll also premiere our new Lightning Round - quick questions and inspired answers.
See you next week. #Biorasi2025 #neuroscience #CROs
October 23, 2025 at 12:37 PM
The new @biorasi.bsky.social video podcast debuts next week!
Host Chris O'Brien welcomes guest Bruce Leuchter, M.D., President and CEO of #neurvati. We'll also premiere our new Lightning Round - quick questions and inspired answers.
See you next week. #Biorasi2025 #neuroscience #CROs
Host Chris O'Brien welcomes guest Bruce Leuchter, M.D., President and CEO of #neurvati. We'll also premiere our new Lightning Round - quick questions and inspired answers.
See you next week. #Biorasi2025 #neuroscience #CROs
When is the right time for a biotech to bring in a Chief Marketing Officer/CMO?
Find out on the @biorasi.bsky.social Few & Far Between podcast, with guest Ken Suzuki, CMO at #NautilusBio. Listen in on your favorite streaming platform or visit >> bit.ly/FewandFarBet... #Biorasi2025
Find out on the @biorasi.bsky.social Few & Far Between podcast, with guest Ken Suzuki, CMO at #NautilusBio. Listen in on your favorite streaming platform or visit >> bit.ly/FewandFarBet... #Biorasi2025
October 22, 2025 at 12:28 PM
When is the right time for a biotech to bring in a Chief Marketing Officer/CMO?
Find out on the @biorasi.bsky.social Few & Far Between podcast, with guest Ken Suzuki, CMO at #NautilusBio. Listen in on your favorite streaming platform or visit >> bit.ly/FewandFarBet... #Biorasi2025
Find out on the @biorasi.bsky.social Few & Far Between podcast, with guest Ken Suzuki, CMO at #NautilusBio. Listen in on your favorite streaming platform or visit >> bit.ly/FewandFarBet... #Biorasi2025
Tune in tomorrow for a new episode of the @biorasi.bsky.social Few & Far Between podcast, with guest Kentaro Suzuki, Chief Marketing Officer at #NautilusBio. Join us as we discover the marketer inside each of us and the lost art of storytelling in #biotech. #Biorasi2025 #clinicaltrials
October 21, 2025 at 12:25 PM
Tune in tomorrow for a new episode of the @biorasi.bsky.social Few & Far Between podcast, with guest Kentaro Suzuki, Chief Marketing Officer at #NautilusBio. Join us as we discover the marketer inside each of us and the lost art of storytelling in #biotech. #Biorasi2025 #clinicaltrials
Wishing everyone a very Happy Diwali! May this festival bring you light, joy, and prosperity! 🪔🌟✨
October 20, 2025 at 4:22 PM
Wishing everyone a very Happy Diwali! May this festival bring you light, joy, and prosperity! 🪔🌟✨
BIG ANNOUNCEMENT!
@biorasi.bsky.social is partnering with @quotientsciences.bsky.social to deliver a streamlined pathway from first-in-human studies to patient proof-of-concept — all under a single CRO/CDMO model.
You can read the full press release at >> bit.ly/3W4ODcM #Biorasi2025 #CRO #CDMO
@biorasi.bsky.social is partnering with @quotientsciences.bsky.social to deliver a streamlined pathway from first-in-human studies to patient proof-of-concept — all under a single CRO/CDMO model.
You can read the full press release at >> bit.ly/3W4ODcM #Biorasi2025 #CRO #CDMO
Quotient Sciences and Biorasi partner to accelerate early phase clinical trials to patient proof-of-concept
/PRNewswire/ -- Quotient Sciences, a leading global drug development, research and manufacturing accelerator, and Biorasi, a global clinical research...
bit.ly
October 14, 2025 at 3:41 PM
BIG ANNOUNCEMENT!
@biorasi.bsky.social is partnering with @quotientsciences.bsky.social to deliver a streamlined pathway from first-in-human studies to patient proof-of-concept — all under a single CRO/CDMO model.
You can read the full press release at >> bit.ly/3W4ODcM #Biorasi2025 #CRO #CDMO
@biorasi.bsky.social is partnering with @quotientsciences.bsky.social to deliver a streamlined pathway from first-in-human studies to patient proof-of-concept — all under a single CRO/CDMO model.
You can read the full press release at >> bit.ly/3W4ODcM #Biorasi2025 #CRO #CDMO
We’re at #OCT2025 New England this week. Meet up with Biorasi’s Nancy Newark and Rob Royall at Booth 17a to talk clinical trials, team collaboration, and quality data sciences solutions.
Schedule time with our team >> bit.ly/ContactBiora... #Biorasi2025 #biotech #biopharma
Schedule time with our team >> bit.ly/ContactBiora... #Biorasi2025 #biotech #biopharma
October 13, 2025 at 1:02 PM
We’re at #OCT2025 New England this week. Meet up with Biorasi’s Nancy Newark and Rob Royall at Booth 17a to talk clinical trials, team collaboration, and quality data sciences solutions.
Schedule time with our team >> bit.ly/ContactBiora... #Biorasi2025 #biotech #biopharma
Schedule time with our team >> bit.ly/ContactBiora... #Biorasi2025 #biotech #biopharma